Comparing Promacta vs Rituximab
| Promacta | Rituximab |
|
|---|
| Promacta (eltrombopag) | Rituximab |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Promacta is an oral tablet or suspension that is taken daily to boost platelet numbers in people with chronic ITP, severe aplastic anemia, or chronic hepatitis C. Nausea, diarrhea, infections, and... View more |
Prescription only
Rituximab (brand name Rituxan) is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia... View more |
Related suggestions Immune Thrombocytopenia
Thrombocytopenia
Popular comparisons
|
|||||||
| More about Promacta (eltrombopag) | More about Rituximab | ||||||||
| Ratings & Reviews | |||||||||
|
Promacta has an average rating of 7.3 out of 10 from a total of 18 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 20% reported a negative effect. |
Rituximab has an average rating of 7.7 out of 10 from a total of 155 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
| Drug Class | |||||||||
| Side Effects | |||||||||
|
See also: Promacta side effects in more detail. |
See also: rituximab side effects in more detail. |
||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Promacta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Other eltrombopag brands include: Alvaiz | Riabni, Rituxan, Ruxience, Truxima | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
|
35 hours |
59.8 hours |
||||||||
| CSA Schedule ** View glossary of terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 181 drugs are known to interact with Promacta:
|
A total of 164 drugs are known to interact with rituximab:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 20, 2008 |
N/A |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
|
|||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.